HealthQuill Pfizer Inc
An advisory panel of the national public agency of the US, Centers for Disease Control and Prevention, has provisionally recommended Pfizer’s vaccine for respiratory syncytial virus in pregnant women to protect infants during the infection season.
Drugs Health Pharma

CDC panel backs Pfizer’s respiratory virus vaccine to protect infants 

HQ Team September 23, 2023: An advisory panel of the national public agency of the US, Centers for Disease Control and Prevention, has.

Read More
The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss or alopecia aerate.
Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German partner BioNTech SE that targets Omicron XBB.1.5 subvariant alone.
Drugs Health Pharma

Pfizer, BioNTech’s Covid-19 variant vaccine gets UK nod

HQ Team September 6, 2023: Britain’s Medicines and Healthcare products Regulatory Agency has cleared a vaccine made by Pfizer Inc., and its German.

Read More
Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through gene therapy.
Drugs Medical Pharma

FDA, EMA accept Pfizer’s BLP application for hemophilia therapy

HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.

Read More
Alembic cancer treatment drug
Drugs Medical Pharma

Sun Pharma buys three anti-inflammatory drug brands from Aksigen

Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.

Read More